XML 33 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Restatement of Previously Issued Financial Statements (Tables)
9 Months Ended
Dec. 30, 2017
Notes Tables  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   
Consolidated Statements of Earnings (Loss)
 
   
Three Months Ended
 
    December 30, 2017 (Unaudited)     December 31, 2016 (Unaudited)  
   
As
           
As
   
As
           
As
 
   
Reported
   
Correction
   
Restated
   
Reported
   
Correction
   
Restated
 
Net Sales
  $
392,714
    $
(5,025
)   $
387,689
    $
369,705
    $
(12,938
)   $
356,767
 
Cost of Products Sold
   
361,013
     
(3,825
)    
357,188
     
332,230
     
(13,389
)    
318,841
 
Gross Profit
   
31,701
     
(1,200
)    
30,501
     
37,475
     
451
     
37,926
 
Operating Income/(Loss)
   
11,471
     
(1,200
)    
10,271
     
13,890
     
451
     
14,341
 
Earnings/(Loss) Before Income Taxes
   
7,459
     
(1,200
)    
6,259
     
11,809
     
451
     
12,260
 
Income Tax (Benefit) Expense
   
(268
)    
2,150
     
1,882
     
3,628
     
843
     
4,471
 
Net Earnings (Loss)
   
7,727
     
(3,350
)    
4,377
     
8,181
     
(392
)    
7,789
 
Earnings Per Common Share-Basic
  $
0.79
    $
(0.34
)   $
0.45
    $
0.83
    $
(0.04
)   $
0.79
 
Earnings Per Common Share-Diluted
  $
0.78
    $
(0.34
)   $
0.44
    $
0.82
    $
(0.04
)   $
0.78
 
   
Nine Months Ended
 
   
December 30, 2017 (Unaudited)
   
December 31, 2016 (Unaudited)
 
   
As
           
As
   
As
           
As
 
   
Reported
   
Correction
   
Restated
   
Reported
   
Correction
   
Restated
 
Net Sales
  $
1,049,209
    $
(34,123
)   $
1,015,086
    $
979,566
    $
1,942
    $
981,508
 
Cost of Products Sold
   
981,344
     
(29,705
)    
951,639
     
891,904
     
(1,302
)    
890,602
 
Gross Profit
   
67,865
     
(4,418
)    
63,447
     
87,662
     
3,244
     
90,906
 
Operating Income/(Loss)
   
13,893
     
(4,418
)    
9,475
     
26,689
     
3,244
     
29,933
 
Earnings/(Loss) Before Income Taxes
   
3,252
     
(4,418
)    
(1,166
)    
20,480
     
3,244
     
23,724
 
Income Tax (Benefit) Expense
   
(2,524
)    
919
     
(1,605
)    
6,217
     
1,932
     
8,149
 
Net Earnings (Loss)
   
5,776
     
(5,337
)    
439
     
14,263
     
1,312
     
15,575
 
Earnings Per Common Share-Basic
  $
0.59
    $
(0.55
)   $
0.04
    $
1.44
    $
0.14
    $
1.58
 
Earnings Per Common Share-Diluted
  $
0.58
    $
(0.54
)   $
0.04
    $
1.43
    $
0.14
    $
1.57
 
   
Consolidated Balance Sheets
 
    As of December 30, 2017 (Unaudited)     As of March 31, 2017 (Audited)  
   
As
           
As
   
As
           
As
 
 
 
Reported
   
Correction
   
Restated
   
Reported
   
Correction
   
Restated
 
Assets
                                               
Inventory
  $
710,118
    $
60,584
    $
770,702
    $
598,056
    $
30,879
    $
628,935
 
Total Current Assets
   
794,510
     
60,584
     
855,094
     
688,270
     
30,879
     
719,149
 
Total Assets
   
1,072,003
     
62,234
     
1,134,237
     
946,019
     
32,249
     
978,268
 
                                                 
Liabilities and Stockholders' Equity
                                               
Deferred Revenue
  $
545
    $
79,606
    $
80,151
    $
545
    $
45,555
    $
46,100
 
Total Current Liabilities
   
162,423
     
79,610
     
242,033
     
132,277
     
45,487
     
177,764
 
Total Liabilities
   
635,204
     
76,628
     
711,832
     
511,758
     
41,306
     
553,064
 
Stockholders' Equity
   
436,799
     
(14,394
)    
422,405
     
434,261
     
(9,057
)    
425,204
 
Total Liabilities and Stockholders' Equity
   
1,072,003
     
62,234
     
1,134,237
     
946,019
     
32,249
     
978,268
 
   
As of December 31, 2016 (Unaudited)
 
   
As
           
As
 
 
 
Reported
   
Correction
   
Restated
 
Assets
                       
Inventory
  $
656,368
    $
43,077
    $
699,445
 
Total Current Assets
   
750,156
     
43,077
     
793,233
 
Total Assets
   
1,004,711
     
49,035
     
1,053,746
 
                         
Liabilities and Stockholders' Equity
                       
Deferred Revenue
  $
473
    $
60,080
    $
60,553
 
Total Current Liabilities
   
178,732
     
60,039
     
238,771
 
Total Liabilities
   
587,097
     
60,039
     
647,136
 
Stockholders' Equity
   
417,614
     
(11,004
)    
406,610
 
Total Liabilities and Stockholders' Equity
   
1,004,711
     
49,035
     
1,053,746